Carisma Therapeutics, Inc. (CARM)

Carisma Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	46	118	124	163	175	109
Market Cap Growth	190.44%	-4.32%	-23.98%	-6.90%	60.39%	-1.02%
Enterprise Value	-3	44	112	-0	119	61
PE Ratio	-	-1.36	-2.02	-483.82	-7.74	-1.01
PS Ratio	3.03	7.93	12.57	6.12	15.54	-
PB Ratio	4.19	4.46	-0.79	0.95	-18.92	-4.08
P/FCF Ratio	-1.16	-1.44	-12.64	-2.36	-5.66	-2.89
P/OCF Ratio	-1.17	-1.46	-24.16	-2.36	-5.66	-2.90
EV/Sales Ratio	2.83	2.93	11.36	0.00	10.61	-
EV/EBITDA Ratio	-0.56	-0.54	-2.15	0.01	-5.72	-0.57
EV/EBIT Ratio	-0.50	-0.49	-1.92	0.01	-5.69	-0.56
EV/FCF Ratio	-0.54	-0.53	-11.43	0.00	-3.87	-1.61
Debt / Equity Ratio	0.69	0.12	-0.26	-	-	-
Debt / EBITDA Ratio	-0.10	-0.04	-0.77	-	-	-
Debt / FCF Ratio	-0.09	-0.04	-4.11	-	-	-
Quick Ratio	4.30	4.88	2.64	16.18	3.07	5.65
Current Ratio	4.64	5.06	2.78	17.77	3.48	6.39
Asset Turnover	0.15	0.12	0.06	0.12	0.10	0
Interest Coverage	-	-	-18.47	-	-	-
Return on Equity (ROE)	-216.00%	-154.00%	-75.80%	-0.30%	905.70%	-1472.80%
Return on Assets (ROA)	-80.60%	-71.60%	-36.30%	-0.10%	-20.60%	-92.10%
Return on Capital (ROIC)	-463.75%	-299.21%	48.04%	-38.08%	349.59%	138.09%
Earnings Yield	-177.73%	-73.47%	-49.54%	-0.21%	-12.91%	-98.74%
FCF Yield	-173.06%	-69.61%	-7.91%	-42.37%	-17.67%	-34.59%
Dividend Yield	0.00%	12.30%	0.00%	0.00%	0.00%	0.00%
Payout Ratio	0.00%	-13.90%	0.00%	-	0.00%	0.00%
Buyback Yield / Dilution	-220.24%	-1475.33%	76.66%	-54.22%	-30.01%	-47.20%
Total Shareholder Return	-220.24%	-1463.03%	76.66%	-54.22%	-30.01%	-47.20%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).